Characteristic | An | An | Oh | Lian | Benegas | Wang | Kim | Esmailiejah |
---|---|---|---|---|---|---|---|---|
Publication year | 2010 | 2012 | 2012 | 2013 | 2014 | 2015 | 2015 | 2015 |
Study design | Retro | Retro | Pro | RCT | RCT | Pro | RCT | RCT |
No. of enrolled patients (MIPO vs CFT) | 17:16 | 15:19 | 29:30 | 24:23 | 21:19 | 26:27 | 36:36 | 33:35 |
No. of followed patients (MIPO vs CFT) | 17:16 | 15:19 | 29:30 | 24:23 | 21:19 | 22:23 | 36:32 | 32:33 |
Follow-up rate (%; MIPO vs CFT) | 100:100 | 100:100 | 100:100 | 100:100 | 100:100 | 84.6:85.2 | 100:88.9 | 97.0:94.3 |
Mean follow-up time (months; MIPO vs CFT) | 25.94:32.88 | 24.2:20.5 | 18:22 | 14:15 | 12:12 | 12:12 | 15 | N/A |
Mean age (years; MIPO vs CFT) | 37.59:36.93 | 34.4:39.6 | 39.6:42 | 38.8:37.6 | 44.8:38.4 | 39.3:35.7 | 40.6:44.4 | 33.4:34.6 |
Gender (% male; MIPO vs CFT) | 70.6:56.3 | 73.3:63.2 | 55.2:53.3 | 62.5:69.6 | 57.1:73.7 | 63.6:69.6 | 52.8:56.3 | 75:72.7 |
Fracture location (proximal/middle/distal; MIPO vs CFT) | 0/8/9:0/9/7 | 0/15/0:0/19/0 | 6/18/5:5/20/5 | 0/24/0:0/23/0 | N/A | 4/13/5:2/15/6 | 4/21/11:4/16/12 | N/A |
Fracture classification* (A/B/C; MIPO vs CFT) | N/A | 6/7/2:10/8/1 | 11/11/7:15/8/7 | 9/9/5:8/12/2 | 12/7/2:9/4/6 | 5/8/9:5/12/6 | 19/17/0:21/11/0 | 10/9/13:12/10/11 |
Intervention (MIPO vs CFT) | DCP vs DCP | DCP vs IMN | LCP vs LCP | DCP vs IMN | DCP vs IMN | LCP vs LCP | LCP vs LCP | DCP vs DCP |